中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
21期
106-107,110
,共3页
非酒精性脂肪肝%血糖%血脂%肝功酶学
非酒精性脂肪肝%血糖%血脂%肝功酶學
비주정성지방간%혈당%혈지%간공매학
Non-alcoholic fatty liver disease%Blood sugar%Blood lipid%Enzymology of liver function
目的：分析非酒精性脂肪肝患者的血脂、血糖及肝功酶学指标的变化情况及检测意义。方法选取2012年1月~2014年8月在本院体检中发现的300例非酒精脂肪肝且无病毒性肝炎患者设为观察组，并选取本院同期接受体检的300例健康者作为对照组，对两组的血脂、血糖及肝功酶学指标进行检测和比较。结果观察组患者的血糖、血脂水平高于对照组，差异有统计学意义(P<0.05)；观察组患者的GGT、ALT、AST水平分别为(53.20±9.37)、(54.88±9.08)、(53.58±7.89)U/L，显著高于对照组的(29.25±8.56)、(23.87±6.08)、(22.87±5.12) U/L(P<0.05)。结论加强非酒精性脂肪肝患者的血糖、血脂和肝功酶学指标监测有助于疾病的早期发现和防治，具有重要的临床价值。
目的：分析非酒精性脂肪肝患者的血脂、血糖及肝功酶學指標的變化情況及檢測意義。方法選取2012年1月~2014年8月在本院體檢中髮現的300例非酒精脂肪肝且無病毒性肝炎患者設為觀察組，併選取本院同期接受體檢的300例健康者作為對照組，對兩組的血脂、血糖及肝功酶學指標進行檢測和比較。結果觀察組患者的血糖、血脂水平高于對照組，差異有統計學意義(P<0.05)；觀察組患者的GGT、ALT、AST水平分彆為(53.20±9.37)、(54.88±9.08)、(53.58±7.89)U/L，顯著高于對照組的(29.25±8.56)、(23.87±6.08)、(22.87±5.12) U/L(P<0.05)。結論加彊非酒精性脂肪肝患者的血糖、血脂和肝功酶學指標鑑測有助于疾病的早期髮現和防治，具有重要的臨床價值。
목적：분석비주정성지방간환자적혈지、혈당급간공매학지표적변화정황급검측의의。방법선취2012년1월~2014년8월재본원체검중발현적300례비주정지방간차무병독성간염환자설위관찰조，병선취본원동기접수체검적300례건강자작위대조조，대량조적혈지、혈당급간공매학지표진행검측화비교。결과관찰조환자적혈당、혈지수평고우대조조，차이유통계학의의(P<0.05)；관찰조환자적GGT、ALT、AST수평분별위(53.20±9.37)、(54.88±9.08)、(53.58±7.89)U/L，현저고우대조조적(29.25±8.56)、(23.87±6.08)、(22.87±5.12) U/L(P<0.05)。결론가강비주정성지방간환자적혈당、혈지화간공매학지표감측유조우질병적조기발현화방치，구유중요적림상개치。
Objective To analyze changes and detection significance of indices of blood lipid,blood sugar and enzymol-ogy of liver function for patients with non-alcoholic fatty liver disease. Methods 300 patients with non-alcoholic fatty liver disease and non-viral hepatitis who were detected in physical examination in our hospital from January 2012 to August 2014 were selected as observation group.300 healthy subjects who received physical examination during the same period of time were selected as control group.Indices of blood lipid,blood sugar and enzymology of liver function were tested and compared between two groups. Results Levels of blood sugar and blood lipid in the observation group were higher than those in the control group,the difference was significant(P<0.05).Levels of GGT,ALT and AST in t ob-servation group respectively were (53.20±9.37),(54.88±9.08) and (53.58±7.89) U/L,which were significantly higher than those of the control group [(29.25±8.56), (23.87±6.08) and (22.87±5.12) U/L] (P<0.05). Conclusion Strengthening the monitoring of indices of blood lipid,blood sugar and enzymology of liver function for patients with non-alcoholic fatty liver disease helps early detection,prevention and treatment of diseases,which is of significant clinical value.
